Mixtures of sulfated oligosaccharides

Details Mixtures of sulfated oligosaccharides Mixtures of sulfated oligosaccharides

2011-08-23

2011-08-23

Jiang, Shaojia Anna (Department: 1623)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Carbohydrate doai

C536S021000, C536S056000

Reexamination Certificate

active

08003623

ABSTRACT:
The present invention relates to mixtures of polysaccharides derived from heparin having a mean molecular weight of 1500 to 3000 Daltons and an anti-Xa/anti-IIa ratio greater than 30, their method of preparation and pharmaceutical compositions containing them.

REFERENCES:
patent: 4168377 (1979-09-01), Choay et al.
patent: 4401662 (1983-08-01), Lormeau et al.
patent: 4401758 (1983-08-01), Lormeau et al.
patent: 4440926 (1984-04-01), Mardiguian et al.
patent: 4474770 (1984-10-01), Lormeau et al.
patent: 4500519 (1985-02-01), Lormeau et al.
patent: 4533549 (1985-08-01), Lasker
patent: 4686288 (1987-08-01), Lormeau et al.
patent: 4826827 (1989-05-01), Lormeau et al.
patent: 4981955 (1991-01-01), Lopez
patent: 4987222 (1991-01-01), De Ambrosi et al.
patent: 5380716 (1995-01-01), Conrad et al.
patent: 5389618 (1995-02-01), Debrie
patent: 5576304 (1996-11-01), Kakkar et al.
patent: RE35770 (1998-04-01), Lormeau et al.
patent: 5739115 (1998-04-01), Fugedi et al.
patent: 6001820 (1999-12-01), Hirsh et al.
patent: 6075013 (2000-06-01), Weitz et al.
patent: 6103705 (2000-08-01), Uzan et al.
patent: 6197943 (2001-03-01), Casu et al.
patent: 6384021 (2002-05-01), Mardiguian
patent: 6617316 (2003-09-01), Mourier et al.
patent: RE38743 (2005-06-01), Debrie
patent: 6969705 (2005-11-01), Pecquet et al.
patent: 2002/0055621 (2002-05-01), Diaz et al.
patent: 2005/0090561 (2005-04-01), Laux et al.
patent: 2005/0171055 (2005-08-01), Pecquet et al.
patent: B-70519/81 (1981-11-01), None
patent: 0 027 089 (1981-04-01), None
patent: 0 037 319 (1981-10-01), None
patent: 0 040 144 (1982-11-01), None
patent: 0 114 589 (1984-08-01), None
patent: 0 293 539 (1988-12-01), None
patent: 0 293 539 (1988-12-01), None
patent: 0 293 539 (1988-12-01), None
patent: 1 070 503 (2001-01-01), None
patent: 2 077 533 (1995-11-01), None
patent: 2 663 639 (1991-12-01), None
patent: WO 81 02737 (1981-10-01), None
patent: WO 98 55515 (1998-12-01), None
patent: WO 01/29055 (2001-04-01), None
patent: WO 02 08295 (2002-01-01), None
English language Derwent abstract of EP 0 027 089 A1.
English language Derwent abstract of EP 0 037 319 A1.
English language Derwent abstract of EP 0 040 144 A1.
English language Derwent abstract of EP 0 293 539 A2.
English language Derwent abstract of ES 2 077 533 A1.
English language Derwent abstract of FR 2 663 639 A1.
English language Derwent abstract of WO 81 02737 A1.
Teien et al., “Evaluation of a Amidolytic Heparin Assay Method: Increased Sensitivity by Adding Purified Antithrombin III,” Thromb. Res., vol. 10, pp. 399-410 (1977).
Vila, P. et al., “Preparation of Saccharide Oligomers by Chemical Depolymerization of Heparin Derivatives,” Chemical Abstracts Service, Database Accession No. 125:303695 w, pp. 163-164, Dec. 9, 1996.
Office Action dated Jul. 30, 2002 in U.S. Appl. No. 09/909,797.
Office Action dated Mar. 11, 2003 in U.S. Appl. No. 09/909,797.
Office Action dated Jul. 14, 2003 in U.S. Appl. No. 09/909,797.
Office Action dated May 17, 2004 in U.S. Appl. No. 09/909,797.
Office Action dated Jan. 21, 2005 in U.S. Appl. No. 09/909,797.
Office Action dated Aug. 29, 2007, in U.S. Appl. No. 10/899,618.
Office Action dated Jun. 5, 2008, in U.S. Appl. No. 10/899,618.
Office Action dated Feb. 18, 2009 in U.S. Appl. No. 10/899,618.
Office Action dated Mar. 31, 2006 in U.S. Appl. No. 11/096,146.
Office Action dated Nov. 22, 2006 in U.S. Appl. No. 11/096,146.
Office Action dated Aug. 6, 2007 in U.S. Appl. No. 11/096,146.
Office Action dated May 5, 2008, in U.S. Appl. No. 11/096,146.
Office Action dated Feb. 17, 2009 in U.S. Appl. No. 11/096,146.
Anderson, L. O. et al., “Molecular Weight Dependency of the Heparin Potentiated Inhibition of Thrombin and Activated Factor X, Effect of Heparin Neutralization in Plasma,”Thromb. Res.,vol. 15, pp. 531-541 (1979).
Barrowcliffe et al., “Anticoagulant Activities of Lung and Mucous Heparins,”Thromb. Res.,vol. 12, pp. 27-36 (1977).
Barrowcliffe et al., “Standardization of Low Molecular Weight Heparins: A Collaborative Study,”Thombosis and Haemostasis,vol. 54, pp. 675-679 (1985).
Barrowcliffe, T.W., “An International Standard for Low Molecular Weight Heparin,”Thrombosis and Haemostasis,vol. 60, pp. 1-7 (1988).
Choay, Jean et al., “Structural Studies on a Biologically Active Hexasaccharide Obtained from Heparin,”Annals of the New York Academy of Sciences,vol. 370, pp. 644-649 (1981).
Galezowski, W. et al., “Homoconjugated Hydrogen Bonds with Amidine and Guanidine Bases. Osmometric,Potentiometric and FTIR Studies,”J. Chem. Soc. Faraday Transactions,93(15), pp. 2515-2518 (1997).
Hook, M. et al., “Anticoagulant Activity of Heparin: Separation of High-Activity and Low-Activity Heparin Species by Affinity chromatography on Immobilized Antithrombin,”F.E.B.S. Letters, vol. 66, No. 1, pp. 90-93 (1976).
Lane, D.A. et al., “Anticoagulant Activities of Four Unfractionated and Fractionated Heparins,”Thromb. res.,vol. 12, pp. 257-271 (1978).
Schwesinger, R. et al., “Peralkylated Polyaminophosphazenes Extremely Strong, Neutral Nitrogen Bases,”Angew. Chem. Int. Ed. Engl.,vol. 26, pp. 1167-1169 (1987).
Schwesinger, R. et al., “How Strong and How Hindered Can Uncharged Phosphazene Bases Be?,”Angew. Chem. Int. Ed. Engl.,vol. 32, No. 9, pp. 1361-1363 (1993).
Teien et al., “Evaluation of a Amidolytic Heparin Assay Method: Increased Sensitivity by Adding Purified Antithrombin III,”Thromb. Res.,vol. 10, pp. 399-410 (1977).
International Search Report mailed Dec. 6, 2001, for PCT Application No. PCT/FR01/02332, filed Jul. 18, 2001 (4 pages).
Declaration Pursuant to 37 C.F.R. § 1.132 of Dr. Christian Viskov, for U.S. Appl. No. 10/430,435, filed May 7, 2003, including attached Tables 1(a), 1(b), and 2 (8 pages).
Letter by a third party, Ungria Patentes Y Marcas, S.A. of Madrid, Spain, to the European Patent Office during the examination of the EP Application No. 01955436.9.

Affiliated with

Also associated with

Rating

Mixtures of sulfated oligosaccharides does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Mixtures of sulfated oligosaccharides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Mixtures of sulfated oligosaccharides will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2718849